Boschini A - Search Results

1

Cutaneous side effects induced by indinavir.

Calista D, Boschini A. Calista D, et al. Among authors: boschini a. Eur J Dermatol. 2000 Jun;10(4):292-6. Eur J Dermatol. 2000. PMID: 10846257

2

Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor.

Calista D, Morri M, Stagno A, Boschini A. Calista D, et al. Among authors: boschini a. Am J Clin Dermatol. 2002;3(1):59-62. doi: 10.2165/00128071-200203010-00006. Am J Clin Dermatol. 2002. PMID: 11817969

3

L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine.

Moretti S, Famularo G, Marcellini S, Boschini A, Santini G, Trinchieri V, Lucci L, Alesse E, De Simone C. Moretti S, et al. Among authors: boschini a. Antioxid Redox Signal. 2002 Jun;4(3):391-403. doi: 10.1089/15230860260196191. Antioxid Redox Signal. 2002. PMID: 12215207 Clinical Trial.

4

Guess What! Localised bacillary angiomatosis of the tongue.

Calista D, Boschini A, Giangaspero F. Calista D, et al. Among authors: boschini a. Eur J Dermatol. 1998 Jun;8(4):283-4. Eur J Dermatol. 1998. PMID: 9917173 No abstract available.

5

Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.

Calista D, Boschini A, Landi G. Calista D, et al. Among authors: boschini a. Eur J Dermatol. 1999 Apr-May;9(3):211-3. Eur J Dermatol. 1999. PMID: 10210787

6

HTLV-II among Italian intravenous drug users and hemophiliacs.

Zanetti AR, Zehender G, Tanzi E, Galli C, Rezza G, Cargnel A, Boschini A, Mari D, Pizzocolo G, Mazzotta F, et al. Zanetti AR, et al. Among authors: boschini a. Eur J Epidemiol. 1992 Sep;8(5):702-7. doi: 10.1007/BF00145387. Eur J Epidemiol. 1992. PMID: 1426170

7

Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy.

Ferretti F, Boschini A, Iabichino C, Gerevini S, De Nardi P, Guffanti M, Balconi G, Lazzarin A, Cinque P. Ferretti F, et al. Among authors: boschini a. BMC Infect Dis. 2011 Dec 14;11:343. doi: 10.1186/1471-2334-11-343. BMC Infect Dis. 2011. PMID: 22168333 Free PMC article.

8

The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.

Cinque P, Bossolasco S, Brambilla AM, Boschini A, Mussini C, Pierotti C, Campi A, Casari S, Bertelli D, Mena M, Lazzarin A. Cinque P, et al. Among authors: boschini a. J Neurovirol. 2003;9 Suppl 1:73-80. doi: 10.1080/13550280390195351. J Neurovirol. 2003. PMID: 12709876 Review.

9

The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy.

Varani S, Spezzacatena P, Manfredi R, Chiodo F, Mastroianni A, Ballarini P, Boschini A, Lazzarotto T, Landini MP. Varani S, et al. Among authors: boschini a. Eur J Epidemiol. 2000 May;16(5):433-7. doi: 10.1023/a:1007619323939. Eur J Epidemiol. 2000. PMID: 10997830 Clinical Trial.

10

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

Zanetti AR, Amendola A, Besana S, Boschini A, Tanzi E. Zanetti AR, et al. Among authors: boschini a. Vaccine. 2002 Dec 20;20 Suppl 5:B29-32. doi: 10.1016/s0264-410x(02)00511-x. Vaccine. 2002. PMID: 12477415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results